Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study

Publication Date

2024

Content Type

Article

PubMed ID:

39055646

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS